Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: hemoptysis major surgical or invasive procedure: bronchoscopy history of present illness: patient is 73m with pmh sig. for lung cancer s/p lobectomy, bilateral pes on coumadin who presented with an acute episode of hemoptysis. pt reports that he was watching tv yesterday evening when he started coughing up blood into his tissue. he feels the blood is running down the r side of his throat. he persisted to cough for about an hour for a total of 2 cups, and drive himself to osh. he noted that walking from the parking lot to the ed, he felt sob. however, this is chronic for him. he also had one episode of hemoptysis about 2.5 weeks ago. a cta from osh showed a new 3.9x2.7 x 2.8 cm l suprahilar mass impinging upon or invading the left pulmonary artery and obstructing l apical segmental bronchus with either tumor or mucus plugging in the adjacent segmental bronchi. inr was 1.9. pt was reversed with 10 mg of vitamin k and 4 units of ffp at osh. in the ed, initial vs: 98.6 103 158/98 20 97 on 3l. cxr shows no infiltrate. ip was made aware. ros: he has doe, feeling sob after walking 15 feet. he has a chronic clear cough. denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, brbpr, melena, hematochezia, dysuria, hematuria. past medical history: dm2 htn copd hl lung cancer s/p rul resection 5 years ago bilateral pes 5 years ago, on coumadin h/o neurofibroma social history: pt usually lives alone but his son has recently moved in with him. retired truck driver. previous smoker of 4ppd x 50 years, quit 5 years ago 2 mo before lung cancer diagnosis. no etoh or drug use. family history: family history: breast cancer--daughter died of metastatic breast cancer at age 35 yo. physical exam: vitals - t: 98.2 bp:115/87 hr:123 rr:22 02 sat:92% on 2l general: nad; seems to have trouble catching his breath heent: perrl; eomi; mucous membranes moist; neck supple; no lymphadenopathy. cardiac: tachycardic; irregular rhythm lung: ctab; decreased breath sounds over upper chest division b/l abdomen: nt nd nl bs ext: 2+ dp; no edema neuro: cn ii-xii intact; normal sensation; 5/5 strength although easily winded. derm:no rashes or ecchymoses pertinent results: admission labs: 01:40am wbc-9.9 hgb-15.1 hct-43.0 01:40am neuts-77* bands-0 lymphs-16* monos-5 eos-2 basos-0 atyps-0 metas-0 myelos-0 01:40am hypochrom-normal anisocyt-normal poikilocy-1+ macrocyt-normal microcyt-1+ polychrom-normal ovalocyt-1+ 01:40am plt count-224 01:40am glucose-201* urea n-18 creat-1.1 sodium-138 potassium-4.3 chloride-101 total co2-23 anion gap-18 12:29pm pt-14.9* ptt-21.3* inr(pt)-1.3* . cxr - 1. post-surgical changes, with volume loss of the right hemithorax. 2. likely small bilateral pleural effusions. 3. increased reticular opacities in the lung bases bilaterally, could reflect a chronic interstitial abnormality. 4. rounded opacity projecting over the left superior hilus, may reflect a vessel or a pulmonary nodule. spirometry: spirometry 10:35 am pre drug post drug actual pred %pred actual %pred %chg fvc 3.40 4.89 70 fev1 1.37 3.21 43 mmf 0.42 2.71 16 fev1/fvc 40 66 61 lung volumes 10:35 am pre drug post drug actual pred %pred actual %pred tlc 5.58 7.76 72 frc 3.25 4.47 73 rv 1.96 2.87 68 vc 3.73 4.89 76 ic 2.33 3.30 71 erv 1.29 1.60 81 rv/tlc 35 37 95 he mix time 1.38 dlco 10:35 am actual pred %pred dsb 13.49 25.51 53 va(sb) 4.72 7.76 61 hb 14.10 dsb(hb) 13.69 25.51 54 dl/va 2.90 3.29 88 radiology fdg tumor imaging (pet- impression: 1. fdg-avid left suprahilar mass, difficult to separate from the hilus. 2. small left apical ill-defined opacity is also fdg-avid, raising concern for a second site of neoplastic involvement. 3. multifocal opacities predominate at the right lung base, likely reflecting infection or aspiration. component of mild volume overload, as described. 4. extensive coronary artery atherosclerotic calcifications. pathology tissue: endobronchial bx, lul squamous cell carcinoma, likely invasive. cytology tbna lymph node station 4l rare groups of atypical epithelial cells with prominent nucleoli present in a background of many bronchial cells and scattered lymphocytes; no definite evidence of lymph node sampling. brief hospital course: 73m with pmhx sig. for lung cancer s/p lobectomy, bilateral pes on coumadin who presented wtih acute sob followed by coughing up 2 cups of hemoptysis. he was admitted to the micu where he received a bronchoscopy that initially showed blood in the l bronchus. he was stabilized and transferred to the medicine floor. a brief description of his hospital stay according to problem is described below: # hemoptysis: his hemoptysis was likely due to his endobronchial lesion and its proximity/involvement with the pulmonary artery. this lesion was found to be squamous cell carcinoma. his coumadin was stopped and he was treated with vit k and ffp at the outside hospital before coming in. his inr was 1.1 on admission to . he had a bronchoscopy that revealed that the bleeding had stopped and he did not have hemoptysis during his hospitalization. he had serial coags for goal inr <1.5, serial hct q8-12 hrs, an active type and screen. tessalon pearls to prevent coughing that could exacerbate the bleed. #lung cancer: patient mass found to be a squamous cell carcinoma. he received a pet with ct scan for staging. he was put into contact with the oncology team to discuss his treatment options. #atrial fibrillation: patient found to have afib in the bronchoscopy suite after his procedure. he was rate controlled with diltiazem while in the hospital. cardiology was consulted and agreed with his discarge dose of diltiazem 480 er once a day. given his recent episode of hemoptysis, anticoagulation was not started given the risk of severe bleeding. he will see in pcp 3 days after discharge to check his rate and adjust the medicine as needed. # dm2: patient's home medication was stopped and he was put on a humalog iss while in house. # copd: patient found to have severe emphysema on ct scan and with plt's. his home advair was continued and he was treated with xoponex and ipratropium nebulizers. this improved his symptoms subjectively. he still required 2-4l of o2 to maintain o2 sats in the 90's and was discharged home with o2 tank. # hyperlipidemia: we continued his home lovastatin # code: dnr/dni # contact: (separated wife, medications on admission: warfarin 5 mg daily metformin 500 mg gemfibrozil 600 mg glyburide 10 mg qam, 7.5 mg qpm mucinex 600mg advair 500 mcg-50 mg inh lovastatin 40 mg daily iron 325 mg mtv discharge medications: 1. oxygen 2-4l continous pulse dose for portability 2. nebulizer machine please provide patient with nebulizer machine and supplies for at home. dx: lung cancer and copd 3. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours) as needed for dyspnea, cough. disp:*28 nebulizers* refills:*0* 4. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily). 5. guaifenesin 600 mg tablet sustained release sig: one (1) tablet sustained release po bid (2 times a day). 6. gemfibrozil 600 mg tablet sig: one (1) tablet po bid (2 times a day). 7. fluticasone-salmeterol 500-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 8. atorvastatin 40 mg tablet sig: one (1) tablet po daily (daily). 9. benzonatate 100 mg capsule sig: one (1) capsule po tid (3 times a day) as needed for cough. 10. codeine-guaifenesin 10-100 mg/5 ml syrup sig: 5-10 mls po q6h (every 6 hours) as needed for cough. disp:*500 ml(s)* refills:*0* 11. diltiazem hcl 240 mg capsule, sustained release sig: two (2) capsule, sustained release po daily (daily). disp:*60 capsule, sustained release(s)* refills:*2* 12. levalbuterol hcl 0.63 mg/3 ml solution for nebulization sig: one (1) solution inhalation q 4 hrs () as needed for wheeze, cough. disp:*120 solution* refills:*0* 13. levofloxacin 250 mg tablet sig: three (3) tablet po q24h (every 24 hours) for 7 days. disp:*21 tablet(s)* refills:*0* 14. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 15. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 16. metformin 500 mg tablet sig: one (1) tablet po twice a day. 17. gemfibrozil 600 mg tablet sig: one (1) tablet po once a day. 18. glyburide 5 mg tablet sig: 1-2 tablets po once a day: take two tablets in the morning and 1.5 in the evening. 19. mucinex 600 mg tablet sustained release sig: one (1) tablet sustained release po twice a day. 20. multivitamin capsule sig: one (1) capsule po once a day. discharge disposition: home with service facility: vna discharge diagnosis: lung cancer discharge condition: stable; atrial fibrillation, rate controlled with diltiazem discharge instructions: you are being sent home with a couple of important medicine changes. . 1. diltiazem 480mg long acting before bed. this medication is for your fast heart rate. whenever you are not taking this, your heart rate increases to an alarming level. it is important that you remember to take every dose of this and that you do not miss a dose. . 2. robitussin with codeine. you can take ml of this whenever you have a cough. preventing a coughing fit can prevent you from coughing blood again, it is important that you have good control of this. . 3. nebulizer machine with ipatropium and xoponex. this treatment helped your breathing. please do this treatment every six hours. . 4. home oxygen. please keep the oxygen on at home. . 5. your coumadin is being stopped due to your risk of bleeding. . 6. levofloxacin 750mg daily for 7 more days. you have an infection, please take this to treat the pneumonia. . you have the following appointment with dr. to make sure that your heart rate is being controlled on the medicine given. md: dr. date and time: tuesday, at 2:15pm location: healthcare - , one pearl st, , , phone number: . your information has been given to the oncology team and they will call you for an appointment to discuss your diagnosis and treatment options. specialty: oncology phone number: special instructions if applicable: you will be called with an appt date, time and oncologist name for an appt. if you do not hear from the office by monday, please call above number. . please return to the er or call your doctor if you cough blood, have increasing shortness of breath, chest pain, fever, or any other alarming symptoms. followup instructions: you have the following appointment with dr. to make sure that your heart rate is being controlled on the medicine given. md: dr. date and time: tuesday, at 2:15pm location: healthcare - , one pearl st, , , phone number: your information has been given to the oncology team and they will call you for an appointment to discuss your diagnosis and treatment options. specialty: oncology phone number: special instructions if applicable: you will be called with an appt date, time and oncologist name for an appt. if you do not hear from the office by monday, please call above number. please return to the er or call your doctor if you cough blood, have increasing shortness of breath, chest pain, fever, or any other alarming symptoms. procedure: fiber-optic bronchoscopy closed [endoscopic] biopsy of bronchus biopsy of lymphatic structure diagnoses: pneumonia, organism unspecified acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified atrial fibrillation personal history of malignant neoplasm of bronchus and lung secondary malignant neoplasm of other specified sites atrial flutter other and unspecified hyperlipidemia long-term (current) use of anticoagulants personal history of venous thrombosis and embolism secondary malignant neoplasm of lung enlargement of lymph nodes secondary and unspecified malignant neoplasm of intrathoracic lymph nodes benign essential hypertension 

Answer: The patient is high likely exposed to